Balance Sheet Data

TherapeuticsMD, Inc. (TXMD)

$4.37

-0.21 (-4.59%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 127.14161.61160.8380.4965.12664.491,111.421,858.943,109.245,200.48
Total Cash (%)
Account Receivables 4.3311.0624.4032.3836.1868.41114.42191.37320.09535.37
Account Receivables (%)
Inventories 1.493.2711.867.997.6221.5636.0660.32100.89168.74
Inventories (%)
Accounts Payable 4.1022.7419.1821.0720.3275.68126.57211.71354.10592.26
Accounts Payable (%)
Capital Expenditure -0.83-21.32-23.89-1.60-2.22-55.41-92.69-155.03-259.29-433.69
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.